This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Monday, April 1, 2013
Type 1 Diabetes Mellitus with Dual Autoimmune Mechanism Related to Pegylated Interferon and Ribavirin Treatment for Chronic HCV Hepatitis
Type 1 Diabetes Mellitus with Dual Autoimmune Mechanism Related to
Pegylated Interferon and Ribavirin Treatment for Chronic HCV
Hepatitis
Cristina Popescu1, 2,
Gabriel-Adrian Popescu1, 2, Victoria Arama1,
2
1) "Prof. dr. Matei Bals" National Institute of Infectious
Diseases
2) "Carol Davila" University of Medicine and Pharmacy Bucharest
Romania Abstract
We report a case of type 1 diabetes
mellitus during pegylated interferon and ribavirin treatment for
chronic
hepatitis C, in a young man previously diagnosed with Hashimoto's
thyroiditis and vitiligo. The diabetes
mellitus occurred during the 12th
month of therapy and the cessation of interferon was necessary.
Besides
anti-islet autoantibodies our patient had also anti-insulin receptor
autoantibodies, which explains the type
B insulin resistance. One year after
interferon discontinuation the patient continues insulin treatment and
all
the pancreatic autoantibodies are still positive. Patients with autoimmune
disorders should be closely
monitored and periodically tested for pancreatic
autoantibodies during interferon treatment, even in the
absence of
hyperglycemia. Key words: type 1 diabetes mellitus -
interferon-alpha side effects - insulin resistance -
hepatitis. Abbreviations: AIRA - anti-insulin receptor
autoantibodies; APS - autoimmune polyglandular syndrome; cANCA - classical
antineutrophil cytoplasmic antibodies; DM - diabetes mellitus; DNA -
deoxyribonucleic acid ; FT4 - free thyroxin; GAD Ab - glutamic acid
decarboxylase antibodies; HbA1c - glycated haemoglobin; HCV - hepatitis C virus;
HLA - human leukocyte antigen; IA-2 Ab- insulinoma associated antigen 2
antibodies; IAA - insulin autoantibodies; ICA - islet cell autoantibodies; NK -
natural killer; PAA - pancreatic associated autoantibodies; pANCA-
protoplasmic-staining antineutrophil cytoplasmic antibodies; T1DM - type 1
diabetes mellitus; TNF - tumor necrosis factor; TSH - thyroid-stimulating
hormone; VL - viral load; ZnT8 Ab - zinc transporter-8 autoantibodies; IL2 -
interleukin 2; IL10 - interleukin 10.
No comments:
Post a Comment